13015-3 |
Diisobutylketone |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Diisobutylketone [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13015-3 |
|
|
|
|
Both |
|
|
|
0 |
Diisobutylketone Bld-mCnc |
|
|
|
Y |
|
Blood; Diisobutyl ketone; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
13016-1 |
Nitrophenol |
ACnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Nitrophenol [Units/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13016-1 |
|
|
|
|
Both |
|
|
|
0 |
Nitrophenol Bld-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Blood; C6H5NO3; DRUG/TOXICOLOGY; Drugs; Mixed isomers; Nitrophenols; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.69 |
1.0j-a |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
13017-9 |
Perchloroethylene |
MCnc |
Bld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Tetrachloroethylene [Mass/volume] in Blood |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13017-9 |
|
|
|
|
|
|
|
|
0 |
Deprecated Perchloroethylene Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.36 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
13018-7 |
Pesticides |
Prid |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Pesticides [Identifier] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13018-7 |
|
|
|
|
Both |
|
|
|
0 |
Pesticides Ur |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13019-5 |
Pesticides |
Prid |
Ser/Plas |
Pt |
Nom |
|
|
ACTIVE |
Pesticides [Identifier] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13019-5 |
|
|
|
|
Both |
|
|
|
0 |
Pesticides SerPl |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
1302-9 |
PP1 Ab |
ACnc |
Ser |
Pt |
Ord |
Aggl RBC |
|
DEPRECATED |
Deprecated PP1 Ab |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1302-9 |
|
Aggl RBC |
|
|
|
|
|
|
0 |
Deprecated PP1 Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.36 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
13020-3 |
Pesticides |
Prid |
Bld |
Pt |
Nom |
|
|
ACTIVE |
Pesticides [Identifier] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13020-3 |
|
|
|
|
Both |
|
|
|
0 |
Pesticides Bld |
|
|
|
|
|
Blood; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; WB; Whole blood |
2.68 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13021-1 |
Pesticides |
Prid |
Gast fld |
Pt |
Nom |
|
|
ACTIVE |
Pesticides [Identifier] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13021-1 |
|
|
|
|
Both |
|
|
|
0 |
Pesticides Gast |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Identity or presence; Nominal; Point in time; Random |
2.19 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13022-9 |
Propane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Propane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13022-9 |
|
|
|
|
Both |
|
|
|
0 |
Propane Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13023-7 |
Trichlorofluoromethane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Trichlorofluoromethane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
13023-7 |
|
|
|
|
Both |
|
|
|
0 |
TCFM Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TCFM; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
13024-5 |
Trichlorofluoroethane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Trichlorofluoroethane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13024-5 |
|
|
|
|
Both |
|
|
|
0 |
TCFE Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TCFE; WB; Whole blood |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
13025-2 |
Trichlorotrifluoroethane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Trichlorotrifluoroethane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13025-2 |
|
|
|
|
Both |
|
|
|
0 |
TCTFE Bld-mCnc |
|
|
|
Y |
|
1,1,2-trichloro-1,2,2-trifluoroethane; Blood; CFC-113; DRUG/TOXICOLOGY; Drugs; FC 133; Freon 113; Freon TF; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TCTFE; Trichloro 1,2,2-trifluoroethane; Trichlorotrifluoromethane; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
13026-0 |
Orthocresol |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Orthocresol [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
13026-0 |
|
|
|
|
Both |
|
|
|
0 |
Orthocresol Ur-mCnc |
|
|
|
Y |
|
1-hydroxy-2-methylbenzene; 2-cresol; 2-hydroxytoluene; 2-methylphenol; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; o-Cresol; o-cresylic acid; o-hydroxytoluene; o-methylphenol; o-methylphenylol; Ortho-cresol; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
13027-8 |
Ethyl acetate |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ethyl acetate [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13027-8 |
|
|
|
|
Both |
|
|
|
0 |
Ethyl Acetate SerPl-mCnc |
|
|
|
Y |
|
Acetic acid; Acetic acid ethyl ester; Acetic ether; Acetoxyethane; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; EtOAc; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
13028-6 |
Xylose^1.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mg/dL;ug/dL |
|
|
|
|
|
|
CHAL |
|
13028-6 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 1.5h p chal SerPl-mCnc |
|
|
|
Y |
|
1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xylose absorption test |
2.4 |
1.0j-a |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
13029-4 |
Xylose^3H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mg/dL;ug/dL |
|
|
|
|
|
|
CHAL |
|
13029-4 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 3h p chal SerPl-mCnc |
|
|
|
Y |
|
3h p chal; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xylose absorption test |
2.4 |
1.0j-a |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
1303-7 |
Reverse ABO group |
Type |
Bld |
Pt |
Nom |
|
|
ACTIVE |
Reverse ABO group [Type] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1303-7 |
|
|
|
|
Observation |
|
|
|
0 |
Reverse ABO Group Bld |
|
|
|
|
|
Blood; BLOOD BANK; Nominal; Point in time; Random; REV; Typ; WB; Whole blood |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
13030-2 |
Xylose^4H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mg/dL;ug/dL |
|
|
|
|
|
|
CHAL |
|
13030-2 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 4h p chal SerPl-mCnc |
|
|
|
Y |
|
4h p chal; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xylose absorption test |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
13031-0 |
Xylose^5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mg/dL;ug/dL |
|
|
|
|
|
|
CHAL |
|
13031-0 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 5h p chal SerPl-mCnc |
|
|
|
Y |
|
5h p chal; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xylose absorption test |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
13032-8 |
C peptide^2nd specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13032-8 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide sp2 p chal SerPl-mCnc |
|
|
|
Y |
|
After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Convalescent; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Post immunization; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
13033-6 |
C peptide^3rd specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13033-6 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide sp3 p chal SerPl-mCnc |
|
|
|
Y |
|
After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
13034-4 |
C peptide^4th specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13034-4 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide sp4 p chal SerPl-mCnc |
|
|
|
Y |
|
After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
13035-1 |
C peptide^5th specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13035-1 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide sp5 p chal SerPl-mCnc |
|
|
|
Y |
|
After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
13036-9 |
C peptide^6th specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13036-9 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide sp6 p chal SerPl-mCnc |
|
|
|
Y |
|
After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
13037-7 |
C peptide^post CFst |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --fasting |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
13037-7 |
|
|
|
|
Both |
|
|
|
0 |
C peptide p fast SerPl-mCnc |
|
|
|
Y |
|
After; Calorie Fast; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Fast; Fasting; Level; Mass concentration; p fast; PC; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |